Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes

Clinical Science

Volumn 115, Issue 5-6, 2008, Pages 167-174

  Lehtihet, Mikael ^a   Efendic, Suad ^b   Brismar, Kerstin ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Diabetes; Glucagon; Insulin like growth factor 1 (IGF 1); Insulin like growth factor binding protein (IFGBP); Obesity

Indexed keywords

C PEPTIDE; GLUCAGON; GROWTH HORMONE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOSTATIN;

ADULT; ARTICLE; ARTIFICIAL PANCREAS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; DRUG EFFECT; METABOLISM; MIDDLE AGED; POSTPRANDIAL STATE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCAGON; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MALE; MIDDLE AGED; OBESITY; POSTPRANDIAL PERIOD; SOMATOSTATIN;

EID: 49649122358     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070372     Document Type: Article

References (62)

1. Boulware, S. D., Tamborlane, W. V., Matthews, L. S. and Sherwin, R. S. (1992) Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism. Am. J. Physiol. 262, E130-E133
2. Sara, V. R. and Hall, K. (1990) Insulin-like growth factors and their binding proteins. Physiol. Rev. 70, 591-614
3. Umpleby, A. M. and Russell-Jones, D. L. (1996) The hormonal control of protein metabolism. Baillieres Clin. Endocrinol. Metab. 10, 551-570
4. Lewitt, M. S. (1994) Role of the insulin-like growth factors in the endocrine control of glucose homeostasis. Diabetes Res. Clin. Pract. 23, 3-15
5. Baxter, R. C. (1986) The somatomedins: insulin-like growth factors. Adv. Clin. Chem. 25, 49-115
6. Rosenzweig, S. A. (2004) What's new in the IGF-binding proteins? Growth Horm. IGF Res. 14, 329-336
7. Baxter, R. C., Martin, J. L. and Beniac, V. A. (1989) High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. J. Biol. Chem. 264, 11843-11848
8. Shimasaki, S. and Ling, N. (1991) Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res. 3, 243-266
9. Lewitt, M. S. and Baxter, R. C. (1991) Insulin-like growth factor-binding protein-1: a role in glucose counterregulation? Mol. Cell. Endocrinol. 79, C147-C152
10. Baxter, R. C. (2000) Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am. J. Physiol. Endocrinol. Metab. 278, E967-E976
11. Frystyk, J., Vestbo, E., Skjaerbaek, C., Mogensen, C. E. and Orskov, H. (1995) Free insulin-like growth factors in human obesity. Metab. Clin. Exp. 44, 37-44
12. Zachrisson, I., Dahlquist, G., Wallensteen, M. and Brismar, K. (2000) Insulin-like growth factor binding protein-1 as glucose regulator in adolescent boys with type 1 diabetes. Acta Paediatr. 89, 1044-1049
13. Frystyk, J. (2004) Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm. IGF Res. 14, 337-375
14. Jones, J. I., D'Ercole, A. J., Camacho-Hubner, C. and Clemmons, D. R. (1991) Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc. Natl. Acad. Sci. U.S.A. 88, 7481-7485
15. Frystyk, J., Grofte, T., Skjaerbaek, C. and Orskov, H. (1997) The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults. J. Clin. Endocrinol. Metab. 82, 3124-3127
16. Brismar, K., Gutniak, M., Povoa, G., Werner, S. and Hall, K. (1988) Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J. Endocrinol. Invest. 11, 599-602
17. Bang, P., Brismar, K., Rosenfeld, R. G. and Hall, K. (1994) Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. J. Clin. Endocrinol. Metab. 78, 960-967
18. Suikkari, A. M., Koivisto, V. A., Koistinen, R., Seppala, M. and Yki-Jarvinen, H. (1989) Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J. Clin. Endocrinol. Metab. 68, 135-140
19. Brismar, K., Fernqvist-Forbes, E., Wahren, J. and Hall, K. (1994) Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 79, 872-878
20. Fernqvist-Forbes, E., Ekberg, K., Lindgren, B. F. and Brismar, K. (1999) Splanchnic exchange of insulin-like growth factor binding protein-1 (IGFBP-1), IGF-1 and acid-labile subunit (ALS) during normo- and hyper-insulinaemia in healthy subjects. Clin. Endocrinol. 51, 327-332
21. Hilding, H., Brismar, K., Degerblad, M., Thoren, M. and Hall, K. (1995) Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J. Clin. Endocrinol. Metab. 80, 2646-2652
22. Bereket, A., Wilson, T. A., Blethen, S. L. et al. (1996) Effect of short-term fasting on free/dissociable insulin-like growth factor I concentrations in normal human serum. J. Clin. Endocrinol. Metab. 81, 4379-4384
23. Orlowski, C. C., Ooi, G. T., Brown, D. R., Yang, Y. W., Tseng, L. Y. and Rechler, M. M. (1991) Insulin rapidly inhibits insulin-like growth factor-binding protein-1 gene expression in H4-II-E rat hepatoma cells. Mol. Endocrinol. 5, 1180-1187
24. Powell, D. R., Suwanichkul, A., Cubbage, M. L., DePaolis, L. A., Snuggs, M. B. and Lee, P. D. (1991) Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J. Biol. Chem. 266, 18868-18876
25. Babajko, S. (1995) Transcriptional regulation of insulin-like growth factor binding protein-1 expression by insulin and cyclic AMP. Growth Regul. 5, 83-91
26. Suwanichkul, A., DePaolis, L. A., Lee, P. D. and Powell, D. R. (1993) Identification of a promoter element which participates in cAMP-stimulated expression of human insulin-like growth factor-binding protein-1. J. Biol. Chem. 268, 9730-9736
27. Suwanichkul, A., Allander, S. V., Morris, S. L. and Powell, D. R. (1994) Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor-binding protein-1 through proximal promoter elements. J. Biol. Chem. 269, 30835-30841
28. Hilding, A., Brismar, K., Thoren, M. and Hall, K. (1993) Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 77, 1142-1147
29. Pierce, A. L., Shimizu, M., Felli, L., Swanson, P. and Dickhoff, W. W. (2006) Metabolic hormones regulate insulin-like growth factor binding protein-1 mRNA levels in primary cultured salmon hepatocytes; lack of inhibition by insulin. J. Endocrinol. 191, 379-386
30. Wallander, M., Brismar, K., Ohrvik, J., Ryden, L. and Norhammar, A. (2006) Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarction. Diabetologia 49, 2247-2255
31. Rajamand, N., Ungerstedt, U. and Brismar, K. (2005) Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus. Diabetes Obes. Metab. 7, 525-535
32. Gutniak, M., Grill, V. and Efendic, S. (1986) Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action. J. Clin. Endocrinol. Metab. 62, 77-83
33. Huggett, A. S. and Nixon, D. A. (1957) Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. Lancet 273, 368-370
34. 1C by isoelectric focusing. Clin. Chem. 28, 9-12
35. Cerasi, E., Della Casa, L., Luft, R. and Roovete, A. (1966) Determination of human growth hormone (HGH) in plasma by a double antibody radioimmunoassay. Acta Endocrinol. 53, 101-120
36. Faloona, G. R. and Unger, R. H. (1974) Biological and immunological activity of pancreatic glucagon and enteric glucagon-like immunoreactivity. Isr. J. Med. Sci. 10, 1324-1331
37. Herbert, V., Lau, K. S., Gottlieb, C. W. and Bleicher, S. J. (1965) Coated charcoal immunoassay of insulin. J. Clin. Endocrinol. Metab. 25, 1375-1384
38. Povoa, G., Roovete, A. and Hall, K. (1984) Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol. 107, 563-570
39. Gutniak, M., Grill, V. and Efendic, S. (1986) Effect of composition of mixed meals: low- versus high-carbohydrate content-on insulin, glucagon, and somatostatin release in healthy humans and in patients with NIDDM. Diabetes Care 9, 244-249
40. Pereira, M. A., Jacobs, Jr, D. R., Pins, J. J. et al. (2002) Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am. J. Clin. Nutr. 75, 848-855
41. Wu, C. J. and Yu, Z. R. (2004) Effects on blood glucose, insulin, lipid and proatherosclerotic parameters in stable type 2 diabetic subjects during an oral fat challenge. Lipids Health Dis. 3, 17
42. Henkel, E., Menschikowski, M., Koehler, C., Leonhardt, W. and Hanefeld, M. (2005) Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus. Metab. Clin. Exp. 54, 1168-1173
43. Tsuchiyama, N., Takamura, T., Ando, H. et al. (2007) Possible role of α-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes. Diabetes Care 30, 2583-2587
44. Brismar, K., Grill, V., Efendic, S. and Hall, K. (1991) The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment. Metab. Clin. Exp. 40, 728-732
45. Clauson, P. G., Brismar, K., Hall, K., Linnarsson, R. and Grill, V. (1998) Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden. Scand. J. Clin. Lab. Invest. 58, 353-360
46. Polonsky, K. S. (1999) Evolution of β-cell dysfunction in impaired glucose tolerance and diabetes. Exp. Clin. Endocrinol. Diabetes 107 (Suppl. 4), S124-S127
47. Ahren, B. (2005) Type 2 diabetes, insulin secretion and β-cell mass. Curr. Mol. Med. 5, 275-286
48. The DECODE study group on behalf of the European Diabetes Epidemiology Group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354, 617-621
49. Lewitt, M. S., Hall, K., Bang, P. and Brismar, K. (2005) Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus. Metab. Clin. Exp. 54, 275-280
50. Holly, J. M., Biddlecombe, R. A., Dunger, D. B. et al. (1988) Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin. Endocrinol. 29, 667-675
51. Baxter, R. C. and Cowell, C. T. (1987) Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J. Clin. Endocrinol. Metab. 65, 432-440
52. Zachrisson, I., Brismar, K., Carlsson-Skwirut, C., Dahlquist, G., Wallensteen, M. and Bang, P. (2000) Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys. Growth Horm. IGF Res. 10, 324-331
53. Degerblad, M., Povoa, G., Thoren, M., Wivall, I. L. and Hall, K. (1989) Lack of diurnal rhythm of low molecular weight insulin-like growth factor binding protein in patients with Cushing's disease. Acta Endocrinol. 120, 195-200
54. Crowne, E. C., Samra, J. S., Cheetham, T. et al. (2001) The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 86, 3686-3691
55. Hilding, A., Moller, C. and Hall, K. (2002) Glucagon and GLP-1 stimulate IGFBP-1 secretion in Hep G2 cells without effect on IGFBP-1 mRNA. Growth Horm. IGF Res. 12, 60-68
56. Ottesen, L. H., Frystyk, J., Kiszka-Kanowitz, M., Gronbaek, H., Bendtsen, F. and Flyvbjerg, A. (2002) Effects of octreotide on serum insulin-like growth factor I and insulin-like growth factor binding proteins in patients with cirrhosis. Scand. J. Clin. Lab. Invest. 62, 39-47
57. Bahcecioglu, I. H., Yalniz, M., Ataseven, H. et al. (2005) Levels of serum hyaluronic acid, TNF-α and IL-8 in patients with nonalcoholic steatohepatitis. Hepatogastroenterology 52, 1549-1553
58. Marchesini, G., Marzocchi, R., Agostini, F. and Bugianesi, E. (2005) Nonalcoholic fatty liver disease and the metabolic syndrome. Curr. Opin. Lipidol. 16, 421-427
59. Hilding, A., Hall, K., Wivall-Helleryd, I. L., Saaf, M., Melin, A. L. and Thoren, M. (1999) Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J. Clin. Endocrinol. Metab. 84, 2013-2019
60. Rojdmark, S., Calissendorff, J., Danielsson, O. and Brismar, K. (2005) Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment. Endocrine 27, 55-61
61. Lewitt, M. S., Saunders, H., Phyual, J. L. and Baxter, R. C. (1994) Regulation of insulin-like growth factor-binding protein-1 in rat serum. Diabetes 43, 232-239
62. Moses, A. C. (2005) Insulin resistance and type 2 diabetes mellitus: is there a therapeutic role for IGF-1? Endocr. Dev. 9, 121-134